Thomas Sirchi
Computational Biologist · Cancer Genomics · Single-Cell & Multi-Omics
About me
I am a computational biologist working in cancer genomics, using high-dimensional molecular data to investigate how tumour cells change state, interact with their microenvironment, and respond to treatment.
My work combines transcriptomics, single-cell biology, multi-omics integration, statistics, and machine learning, with experience across lung cancer and haematological malignancies and an emphasis on reproducible analysis and biologically interpretable results.
Research focus
Cancer ecosystems & plasticity
Tumour heterogeneity, malignant state transitions, metastatic progression, treatment response, and tumour–microenvironment interactions.
Single-cell, spatial & multi-omics
Single-cell transcriptomics, spatial molecular data, and integration of transcriptomic, genomic, and epigenomic measurements.
Computational methodology
Statistical genomics, machine learning, explicit quality control, batch-effect modelling, and reproducible computational workflows.
Computational toolkit
Languages & workflows
Data analysis
Approach
I build reproducible computational workflows for sequencing QC, statistical analysis, integrative modelling, and biological interpretation.
Current focus: tumour heterogeneity, cell-state plasticity, and metastatic progression through single-cell and multi-omic approaches.
Software
veryMAD
Explicit MAD-based quality control and diagnostic visualisation for high-dimensional biological data.
View repository: veryMADveryMADpy
Python/AnnData implementation of explicit MAD-based quality control for modern single-cell workflows.
View repository: veryMADpyComBat-refQL
Reference-batch adjustment for bulk RNA-seq count data using quasi-likelihood modelling and explicit diagnostics.
View repository: ComBat-refQLsimple-nextflow-salmon
Lightweight reproducible Nextflow workflow for RNA-seq quantification with Salmon and integrated QC.
View repository: simple-nextflow-salmonWhat I care about
I am particularly interested in computational approaches that connect molecular measurements with tumour cell state, evolutionary dynamics and phenotype, rather than treating high-dimensional data as an endpoint by itself.